---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-015543"
form_type: "8-K"
ticker: "EUDA"
cik: "0001847846"
company_name: "EUDA Health Holdings Ltd"
filed_at: "2022-06-01T23:59:59+00:00"
generated_at: "2026-06-25T05:36:24.680553+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# 8i Acquisition 2 extends due diligence for EUDA Health combination to June 15, 2022

## Summary
- Parties amended the Share Purchase Agreement on May 30, 2022.
- Due diligence review period extended from May 31, 2022 to June 15, 2022.
- Amendment involves LAX, EUDA Health, Watermark Developments, and representative Kwong Yeow Liew.
- Business combination to be effected through purchase of all EUDA Health shares by LAX.

## SEC filing metadata
- accession: 0001493152-22-015543
- form_type: 8-K
- ticker: EUDA
- cik: 0001847846
- company_name: EUDA Health Holdings Ltd
- filed_at: 2022-06-01T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/0001493152-22-015543-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1847846/000149315222015543/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-015543
- JSON: https://secwatch.observer/filing/0001493152-22-015543.json
- Plain text: https://secwatch.observer/filing/0001493152-22-015543.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.